Join
This site is intended for healthcare professionals
1
Role of Post-Exposure Prophylaxis in COVID-19
2
Screens Driving Horrific Harm to Children’s Health
3
Gut Microbiome Predicts Response to Diabetes Drugs
4
EMJ Innovations 10.1 2026
5
Stem-Cell Therapy Success in China Marks Milestone in Type 1 Diabetes Treatment
Checkpoint-Engineered Particles Induce Food Allergy Tolerance
Simple Fitness Test Predicts Pulmonary Hypertension Outcomes
Photoprotection May Preserve Epigenetic Stability in Human Skin
GLP-1 RAs Reduce Adverse Limb Events in Patients with Diabetes
Scalable chikungunya vaccine breakthrough
EMJ’s Latest Flagship Journal
AI Models Combine Genomics and Demographics to Predict Gastric Cancer Risk
Can Meat Byproducts Be Harnessed to Benefit Gut Health?
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
Targeted Treatment Improved Survival in Cholangiocarcinoma
Rollout of AI Scribe Tools Transform NHS Consultations
Nomogram Predicts Atrial Fibrillation Recurrence After Cryoballoon Ablation
SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes
TBI Linked to Higher Dementia Mortality Risk
AI System Improves MRI Breast Cancer Diagnosis
Computer-Aided Detection Chest X-Ray Matches Radiologists
Light-Triggered Microneedle Patch Aimed at IVF Injections
Do GLP-1 Receptor Agonists Raise Chronic Cough Risk?
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
Immunohistochemical Biomarkers for Prognostic Stratification in Metastatic Prostate Cancer